Actinium Pharmaceuticals (ATNM US)

Analysis

Health Care • United States

Actinium Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops pipeline of antibody radiation conjugates for targeted conditioning and combination therapies. Actinium Pharmaceuticals serves clients in the United States.

Refresh

Company Presentation • 02 Sep 2026 19:00

Investor presentation

Company Presentation • 07 Aug 2026 20:00

Investor presentation

Company Presentation • 08 Dec 2023 20:00

Study update presentation

Company Presentation • 05 Dec 2018 20:00

Study update presentation

Company Presentation • 05 Dec 2017 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00